FinEdge Labs
R

RVTY

RVTYUnverified
2 segments tracked|7 years of data|Annual (10-K)
Total Revenue
$2.9B3.7%
FY2025
Operating Segments
2
Active segments
Blended Margin
0.0%
Operating margin
Highest Margin
0.0%
Life Sciences
Segment Shift

Life Sciences has grown from 0.0% to 50.1% of total revenue since FY2018, with 0.0% operating margins. Meanwhile, Diagnostics is the fastest growing at +5.1% YoY.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2025

SegmentRevenueOp. IncomeMargin% of TotalYoY
Life Sciences$1.4B$00.0%50.1%+2.3%
Diagnostics$1.4B$00.0%49.9%+5.1%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free